amsacrine
Sign in to saveAlso known as Amsidyl, CI-880, M-AMSA, NCI-249992, mAMSA, 4'-(9-Acridinylamino)methanesulfon-m-anisidide, 4'-(9-Acridinylamino)methanesulphon-m-anisidide, 4'-(9-Acridinylamino)methanesulfon-meta-anisidide
Amsacrine (synonyms: m-AMSA, acridinyl anisidide) is an antineoplastic agent.
Research
1,496 papers- Amsacrine: a review.Leukemia research · 1986
- Amsacrine evaluation.Drug intelligence & clinical pharmacy · 1987
- Amsacrine (AMSA).Cancer treatment reviews · 1980
- Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.Toxicology and applied pharmacology · 2023
- Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis.Annals of hematology · 2023
via PubMed
~1 min read
Encyclopedic overview
2 sectionsContents
- Mechanism
- References
Amsacrine (synonyms: m-AMSA, acridinyl anisidide) is an antineoplastic agent.
It has been used in acute lymphoblastic leukemia.
Excerpted from Wikipedia’s “amsacrine” article, available under the CC BY-SA 4.0 licence.
Available in 7 languages
via Wikidata sitelinks · CC0